At UHN, we strive to deliver Compassionate Care & Caring. Learn more about the services and supports that are available to you throughout your journey.
Our UHN programs and services are among the most advanced in the world. We have grouped our physicians,
staff, services and resources into 10 medical programs to meet the needs of our patients and help us make
the most of our resources.
At the heart of everything we do at UHN are our Healthcare Professionals. Refer a patient to one of our 12 medical programs. Learn more about the resources and opportunities available for professional growth.
University Health Network has grown to be one of the largest research and teaching hospital networks in Canada - pioneers in improving the lives of patients. Our long history of health professions education at Toronto General, Toronto Western, Princess Margaret and Toronto Rehab hospitals has consistently advanced the science of education.
University Health Network is a health care and medical research organization in
Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international
source for discovery, education and patient care.
Being touched by illness affects us in different ways. Many people want to give back to the community
and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one
of our experts for an interview. It's also the place to find UHN media policies and catch up on our news stories, videos, media releases,
podcasts and more.
Our four major platforms are established to integrate research with clinical care and to accelerate collection and analyses of high-throughput clinical and biological data required for our epidemiologists, computational scientists, clinical and basic science researchers to enable better understanding of disease mechanisms. These platforms seek to meet the need for reproducible data and to achieve the goals of increasing external peer-reviewed funding and success in large-scale team grant competitions. The platforms will also enhance our productivity by collaborating as one team. The outcomes from projects at these centres are better basic understanding of the diseases, new diagnostic tests, and improved therapies, all ultimately focused on improved patient care. To enable this, our cross-cutting centres and platforms include:
This centre will provide platforms to all the arthritis investigators for high throughput data to maximize the potential of our biobanks for basic understanding for the disease for biomarker and therapeutic target discovery. Services provided in this centre include Next Generation Sequencing (RNA, microRNA, single cell Seq), metabolomics, multiplexing, etc. This centre will also be a key resource for our partner institutes at TWH, the Krembil Brain Institute and the Donald K. Johnson Eye Institute.
This centre will utilize artificial intelligence and advanced bioinformatics to identify biomarkers and predictive algorithms for surgical and medical treatments for arthritis. The centre will also apply advanced bioinformatics for modeling disease mechanisms and defining novel therapeutic targets. The analytics, diagnostics, therapeutics, and translational medicine platforms are all anchored in accurate disease phenotyping, based in longitudinal observation cohorts.
This Centre will focus on responding to the needs of the population with musculoskeletal diseases including autoimmune rheumatic, bone, joint, and spine conditions at the population level. This includes identifying at-risk groups for existing and novel targeted interventions and implementation strategies to bring proven interventions into clinical practice. We will translate these interventions by creating, testing, and implementing new models of care.
This centre will focus on stem cells (manufacturing and testing), biologics, tissue engineering and other novel therapeutics and interventions. It will facilitate and expand our capacity to conduct clinical research and trials.